中进医疗发布公告称，该公司及其关联方尔华医疗不会仅凭可变利益实体（VIE）协议，就取得澄兰康旭或华夏启英的股权法定所有权。
公告明确指出，VIE协议本身不足以构成对公司相关实体股权的法律层面的所有权转移。这一表述意味着，尽管存在协议安排，但法律权属并未随之自动变更。
中进医疗进一步阐释，上述两家企业的股权法律所有权归属，并不因VIE架构的存续而发生变化。换言之，协议的签署与履行，并不等同于对目标公司股权的直接获取。
该公告旨在厘清市场可能存在的误解，强调协议安排与法律所有权之间的界限。中进医疗及尔华医疗在相关协议项下的权利，仅限于合同约定的范畴之内，而非延伸至股权的法律归属层面。
此一澄清对于投资者理解公司治理结构及实际控制关系，具有重要的参考意义。公告内容简洁而明确，直接回应了外界关于VIE协议效力的疑问。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.